Secondly, transgenic animal models of AD should be employed to assess the in vivo effects of prolonged aspartame consumption on key pathological indicators, including Aβ deposition, Tau protein phosphorylation, and neuroinflammation. This evidence concerns the gene MAPT and Alzheimer disease.